September 6, 2007
New CFO for RXi
By Matthew L. Brown
Worcester's RXi Pharmaceuticals Corp. has hired Stephen J. DiPalma as its CFO as former CFO James Warren leaves the company.
DiPalma was most recently the co-founder, president and CEO of Catalyst Oncology Inc., and he has been an executive at a variety of other public and private pharmaceutical, biosciences and drug development companies.
The company said DiPalma would play a role in the development and commercialization of RXi's RNAi gene therapies.
RXi is a subsidiary of Los Angeles, Calif.-based CytRx Corp.
DiPalma was most recently the co-founder, president and CEO of Catalyst Oncology Inc., and he has been an executive at a variety of other public and private pharmaceutical, biosciences and drug development companies.
The company said DiPalma would play a role in the development and commercialization of RXi's RNAi gene therapies.
RXi is a subsidiary of Los Angeles, Calif.-based CytRx Corp.
WBJ Web Partners
Most Recent
Most Recent
0 Comments